Hologic to Showcase Developments in Next-Generation AI Solutions at RSNA 2023
November 24 2023 - 8:05AM
Business Wire
Leader in Women’s Health Will Highlight New
Imaging Solutions That Aid in Cancer Detection and Radiologist
Workflow
Hologic, Inc. (Nasdaq: HOLX) will showcase several recent
developments in next-generation AI solutions at the 109th
Scientific Assembly and Annual Meeting of the Radiological Society
of North America (RSNA) from Nov. 26 to 30. On the show floor and
during multiple workshops, the global leader in breast imaging will
unveil advances that leverage AI to improve cancer detection,
workflow and patient satisfaction.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231124298382/en/
RSAN 2023 (Graphic: Business Wire)
New to Hologic’s portfolio of Breast and Skeletal Health
Solutions is its Genius AI® Detection 2.0 solution, a
next-generation deep-learning technology designed to improve breast
cancer detection while reducing the number of false-positive
markings per case. With more than a 70% reduction in false-positive
markings per case when compared to Hologic’s ImageChecker ® CAD
solution, Genius AI Detection 2.0 technology gives radiologists
confidence that marked lesions are truly suspicious and warrant
further review.1 Additionally, the new SecurView® 12.0 solution
enables more multimodality capabilities, including reading breast
ultrasound cases directly in the SecurView viewer. When paired with
Genius AI Detection 2.0, the new automated lesion correlation
feature is enabled to allow for faster review of specific
lesions.
“We are building on our history of innovation in breast health
with an exciting new AI-based solution that is designed to support
the radiologist with improved cancer detection and a more efficient
workflow — two factors that we know are critical for our
customers,” said Erik Anderson, Division President, Breast and
Skeletal Health Solutions, Hologic. “At this year’s RSNA meeting,
we’re looking forward to engaging with industry leaders and
affirming our commitment to advancing breast health through
cutting-edge technology.”
Genius AI Detection 2.0 technology represents Hologic’s
continued commitment to advancing and refining its AI roadmap.
Customer feedback, research findings and continuous improvements
will inform future iterations of Genius AI Detection technology, as
well as new AI products. Hologic is currently exploring new product
features to drive toward even greater accuracy and efficient breast
care, including:
- Real-time image quality and positioning feedback.
- Short-term risk evaluations.
- Automated reporting tools.
- Smart triage features.
In the South Hall, Level 3, Booth 1919 at McCormick Place,
guests can experience Hologic’s comprehensive portfolio, including
the Dimensions® mammography portfolio, Affirm® Contrast Biopsy
software, I-View® Contrast Enhanced Mammography software and a full
suite of breast biopsy and surgery solutions. Additionally, the
Company will host a CME-accredited symposium and lunch-and-learn
sessions, including:
- Advancements in Breast Imaging with Contrast-Enhanced
Mammography Sunday, Nov. 26: 11:45 a.m. – 12:45 p.m. CST (South
Building, Level 5, Room S502) Join Dr. Chiara Bellini and Dr.
Michael Morris as they explore the latest in Contrast-Enhanced
Mammography and its impact on breast imaging in Europe and the U.S.
In this dynamic session, they will provide a comprehensive
overview, current research, clinic implementation, incorporation of
contrast mammography and much more. Take advantage of this
opportunity to hear from experts in the field on this cutting-edge
technology.
- AI Applications in Mammography Today Monday, Nov. 27:
9:00 a.m. – 10:00 a.m. CST (South Building, Level 1, Room S102AB)
In this CME-accredited symposium, Dr. Samir Patel will share his
experience with Al in mammography, including an engaging discussion
around generated images, 6 mm slices, and advancements in
Al-generated CAD. Dr. Patel will share Al’s impact on clinical
benefits and how best to utilize mammography interpretation,
improving the mammography experience for radiologists,
technologists and patients.
- A Comprehensive Approach to Localization: Understanding the
Benefits of Wire vs. Wire-free Breast Localization Featuring
Hologic's LOCalizer™ Wire-free Guidance System, Tuloc™ Localization
Wire and Tuflex™ Thread Marker Tuesday, Nov. 28: 12:00 p.m. – 1:00
p.m. CST Hear perspectives from leading radiologists Dr. Tchaiko
Parris and Dr. Stacy Smith-Foley on how they select the right
localization technique for their patients. Faculty will review
several options offered by Hologic, such as LOCalizer Wire-free
Guidance System, Tuloc Localization Wire and Tuflex Thread Marker,
including case review.
About Hologic, Inc.
Hologic, Inc. is a global medical technology innovator focused
on improving the health and well-being of women, their families and
communities through early detection and treatment. Its advancements
include the world’s first commercial 3D Mammography™ system to find
breast cancer earlier; leadership in testing for cervical cancer,
sexually transmitted infections and respiratory illnesses; and
minimally invasive surgical technologies for uterine fibroids and
abnormal uterine bleeding.
For more information on Hologic, visit www.hologic.com.
Forward-Looking Statements
This news release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic products. There can be no assurance these products
will achieve the benefits described herein or that such benefits
will be replicated in any particular manner with respect to an
individual patient, as the actual effect of the use of the products
can only be determined on a case-by-case basis. In addition, there
can be no assurance that these products will be commercially
successful or achieve any expected level of sales. Hologic
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any such statements presented
herein to reflect any change in expectations or any change in
events, conditions or circumstances on which any such data or
statements are based.
Hologic, Genius AI, ImageChecker, I-View, LOCalizer, SecurView,
Tuloc, Tuflex and The Science of Sure are trademarks and/or
registered trademarks of Hologic, Inc., and/or its subsidiaries in
the United States and/or other countries.
1 Kshirsagar, A. (2023). Comparison between ImageChecker CAD and
GAID algorithm on sequestered FDA database. Refer to Hologic
document (DHM-14593).
Source: Hologic, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231124298382/en/
Media Contact: Bridget Perry Director, Corporate
Communications +1 508.263.8654 bridget.perry@hologic.com
Investor Contact: Ryan Simon Vice President, Investor
Relations +1 858.410.8514 ryan.simon@hologic.com
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Jul 2023 to Jul 2024